20/20 HealthCare Partners
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact

20/20 HealthCare Partners

26 Feb2019

Hillel Bachrach Serves as Moderator at MIT Sloan School of Management Innovation Panel

Written by 2020HCP.com. Posted in News

Big Data, Digitalization, and Disruption: How are the headline trends of new technology and therapeutic innovation changing how we address today’s biggest healthcare challenges?

HITInfrastructure.com covers the event:

Digital Health Technology Needs to Fit into the Clinical Workflow

The biggest question when it come to digital health technology is not getting “new, cool stuff” into the hospital, but how can it fit seamlessly into the existing clinical workflow, observed Jaydeo Kinikar, head of marketing and business development at Philips Connected Care Sensing.

  • Continue Reading
11 Feb2019

3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies

Written by 2020HCP.com. Posted in News

SHENYANG, China and BOSTON Mass., February 11, 2019 /PRNewswire/ — 3SBio Inc. (“3SBio”) (HKEX:1530) and Verseau Therapeutics, Inc. (“Verseau”) announced today a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of immuno-oncology for a broad range of cancers. Verseau’s proprietary drug discovery platform generates first-in-class macrophage checkpoint modulators (MCMs) to benefit patients with cancer, immune and inflammatory diseases.
  • Continue Reading
06 Feb2019

Omron Healthcare and physIQ Partner to Transform Cardiovascular Patient Care

Written by 2020HCP.com. Posted in News

  • Omron HeartGuide™, the first wearable blood pressure device, will integrate with physIQ’s pinpointIQ® analytics platform to indicate a potential health risk
  • This combined solution is being deployed to help manage recently-discharged, at-risk patients
  • The goal is to provide clinicians with physiological insight to proactively address potential clinical deterioration
CHICAGO, February 6, 2019 – Omron Healthcare, Inc. and physIQ Inc. today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide™, the first wearable blood pressure monitor into the pinpointIQ® platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging the complementary technologies of each company. Omron is the global leader in personal heart health and wellness technology and physIQ is a pioneer in FDA-cleared Artificial Intelligence physiology analytics.
  • Continue Reading
10 Jan2019

VRHealth launches first telehealth-VR health data platform

Written by 2020HCP.com. Posted in News

Partnership with AARP influences new VR Medical Platform

— by Kristi Hansen Onkka This week I met with the founder and CEO of VRHealth, Eran Orr, to take a look at this ground breaking VRHealth telehealth-VR platform. We met at the AARP Innovation Lab booth located within the vastly growing healthcare section of the 2019 Consumer Electronics Show. READ MORE
  • Continue Reading
09 Jan2019

ENCOMPASS ANNOUNCES PARTNERSHIP WITH ZIXI

Written by 2020HCP.com. Posted in News

Encompass Digital Media, a global technology services company delivering end-to-end video playout and distribution solutions to broadcast and digital media companies, announces its partnership with Zixi, the industry leader for enabling dependable, live broadcast-quality video over the internet. Zixi’s proven, best-of-breed solutions coupled with Encompass’ broadcast expertise gives its clients additional economical methods to acquire and deliver content.   READ MORE
  • Continue Reading
  • 1
  • ...
  • 10
  • 11
  • 12
  • 13

Latest News

  • Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe October 18, 2022
  • SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting June 21, 2022
  • SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors April 28, 2022
  • SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo April 11, 2022
  • SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes April 5, 2022

20/20 HealthCare Partners | 2000 Commonwealth Ave, Suite 200, Auburndale, MA 02466 | Contact Us

Copyright © 2019
  • Home
  • What Differentiates 20/20 HCP
  • Team
  • Companies
    • Companies
    • Exits
  • News
  • Contact